Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
Purpose. To investigate the choroidal vascularity index (CVI) as a prognostic factor for the visual efficacy of antivascular endothelial growth factor (VEGF) treatment in diabetic macular edema (DME). Methods. We retrospectively reviewed 92 DME eyes receiving anti-VEGF treatment, which were stratifi...
Saved in:
Main Authors: | Ningxin Dou, Shanshan Yu, Ching-Kit Tsui, Boyu Yang, Jianqiang Lin, Xi Lu, Yue Xu, Benjuan Wu, Jinfeng Zhao, Xiaoling Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2021/3033219 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01) -
Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01) -
Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
by: Jingyuan Yang, et al.
Published: (2019-01-01) -
Abdominal obesity as a predictor for response to anti-vascular endothelial growth factor therapy in patients with diabetic macular edema
by: Tamer E. Wasfy, et al.
Published: (2025-01-01) -
Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
by: Xiaobei Yin, et al.
Published: (2022-01-01)